Galenica AG 2020 AR2
The report outlines the financial and operational performance of the Galenica Group for the fiscal year 2020, highlighting its resilience and systemic relevance during the COVID-19 pandemic. Key achievements include a 5.4% increase in consolidated net sales to CHF 3,479.8 million and the expansion of its offline and online pharmacy network, including the launch of a new mail-order pharmacy service. The company also completed significant acquisitions, such as the Hedoga Group, and successfully relaunched the Vita-Merfen wound ointment. Additionally, Galenica adapted its organizational structure to enhance customer focus and collaboration starting in 2021.
Company: Galenica AG
Sector: Wholesale & retail
Country: Switzerland
Year: 2020
Type: AR2
Pages: 160
Back to company
Galenica AG
Annual Report
The report outlines the financial and operational performance of the Galenica Group for the fiscal year 2020, highlighting its resilience and systemic relevance during the COVID-19 pandemic. Key achievements include a 5.4% increase in consolidated net sales to CHF 3,479.8 million and the expansion of its offline and online pharmacy network, including the launch of a new mail-order pharmacy service. The company also completed significant acquisitions, such as the Hedoga Group, and successfully relaunched the Vita-Merfen wound ointment. Additionally, Galenica adapted its organizational structure to enhance customer focus and collaboration starting in 2021.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Mar 1, 2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management
Employees